Advanced Medical Solutions Group plc (AIM:AMS)
London · Delayed Price · Currency is GBP · Price in GBX 245.50
-2.00 (-0.81%)
May 7, 2026, 1:45 PM GMT
AIM:AMS Market Cap
AIM:AMS has a market cap or net worth of 535.38 million as of May 7, 2026. Its market cap has increased by 36.49% in one year.
Market Cap
535.38M
Enterprise Value
600.20M
Revenue
228.94M
Ranking
n/a
PE Ratio
54.76
Stock Price
245.50
Market Cap Chart
Since April 11, 2000, AIM:AMS's market cap has increased from 11.11M to 535.38M, an increase of 4,720.16%. That is a compound annual growth rate of 16.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 518.07M | 10.18% |
| Dec 31, 2025 | 470.21M | 11.01% |
| Dec 31, 2024 | 423.58M | -6.07% |
| Dec 29, 2023 | 450.96M | -19.69% |
| Dec 30, 2022 | 561.49M | -23.12% |
| Dec 31, 2021 | 730.32M | 39.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.41B |
| GSK plc | 74.85B |
| Haleon | 29.72B |
| Smith & Nephew | 9.54B |
| CVS Group | 798.38M |
| Oxford Biomedica | 779.81M |
| Allergy Therapeutics | 664.92M |
| Spire Healthcare Group | 637.75M |